Bollard Group LLC Pfizer Inc Transaction History

Bollard Group LLC

$4.37 Billion
Q2 2025

A detailed history of Bollard Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bollard Group LLC holds 120 shares of PFE stock, worth $2,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120

Previous 29,582 99.59%

Holding current value

$2,958

Previous $750,000 99.6%

% of portfolio

0.0%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$21.59 - $24.84 $636,084 - $731,836	-29,462 Reduced 99.59%	120 $3,000
Q1 2025 May 15, 2025	SELL	$25.01 - $27.13 $52,420 - $56,864	-2,096 Reduced 6.62%	29,582 $750,000
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $41,440 - $50,447	-1,671 Reduced 5.01%	31,678 $840,000
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $6,703 - $7,596	-242 Reduced 0.72%	33,349 $965,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.07 Million - $1.25 Million	-42,349 Reduced 55.77%	33,591 $940,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $22,032 - $25,300	851 Added 1.13%	75,940 $2.11 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $95,113 - $123,541	-3,640 Reduced 4.62%	75,089 $2.16 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $7,573 - $8,852	236 Added 0.3%	78,729 $2.61 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $16,904 - $19,557	468 Added 0.6%	78,493 $2.88 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $7,956 - $10,358	202 Added 0.26%	78,025 $3.18 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $109,343 - $142,735	-2,619 Reduced 3.26%	77,823 $3.99 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $27,831 - $33,975	-636 Reduced 0.78%	80,442 $3.52 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $7,956 - $9,434	171 Added 0.21%	81,078 $4.25 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $8,829 - $10,941	193 Added 0.24%	80,907 $4.19 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $6,776 - $10,045	164 Added 0.2%	80,714 $4.77 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7,850 - $10,084	200 Added 0.25%	80,550 $3.46 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $8,510 - $9,641	237 Added 0.3%	80,350 $3.15 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $535 - $604	16 Added 0.02%	80,113 $2.9 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $32,934 - $41,879	-984 Reduced 1.21%	80,097 $2.95 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $24,225 - $28,421	-763 Reduced 0.93%	81,081 $2.98 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $166,684 - $202,212	5,534 Added 7.25%	81,844 $2.68 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $219,051 - $312,976	-8,104 Reduced 9.6%	76,310 $2.49 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $18,764 - $21,295	570 Added 0.68%	84,414 $3.31 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $19,851 - $25,741	611 Added 0.73%	83,844 $3.01 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $19,377 - $21,756	524 Added 0.63%	83,233 $3.61 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $19,387 - $21,300	517 Added 0.63%	82,709 $3.51 Million
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $48,318 - $55,088	1,256 Added 1.55%	82,192 $3.59 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $18,648 - $22,619	541 Added 0.67%	80,936 $3.57 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $20,249 - $21,588	614 Added 0.77%	80,395 $2.92 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $19,337 - $22,434	606 Added 0.77%	79,781 $2.83 Million
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $18,858 - $20,009	567 Added 0.72%	79,175 $2.87 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $2.44 Million - $2.68 Million	78,608	78,608 $2.81 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Pfizer Inc Transaction History